N-GENE RESEARCH LABORATORIES, INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for N-GENE RESEARCH LABORATORIES, INC..The latest application filed is for "methods for treating nash and for preventing nash-induced hcc".

Company Profile

2.14.12

N-GENE RESEARCH LABORATORIES, INC. - New York NY
N-Gene Research Laboratories, Inc. -
N-GENE RESEARCH LABORATORIES INC. - 575 Madison Avenue 10th Floor New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Methods for treating NASH and for preventing NASH-induced HCC Grant 11,357,768 - Febbraio , et al. June 14, 2	2022-06-14
Use of BGP15 to treat familial dysautonomia Grant 10,702,514 - Lefcort , et al.	2020-07-07
Methods For Treating Nash And For Preventing Nash-induced Hcc App 20200179363 - FEBBRAIO; Mark Anthony ; et al.	2020-06-11
Use Of Bgp15 To Treat Familial Dysautonomia App 20180000809 - LEFCORT; Frances Brenda ; et al.	2018-01-04
Prevention of Obesity in Antipsychotic, Antidepressant and Antiepileptic Medication App 20150366852 - Nagy; Peter Literati ; et al.	2015-12-24
Synergistic pharmaceutical combination for the prevention or treatment of diabetes Grant 8,048,873 - Szilvassy , et al. November 1, 2	2011-11-01
Prevention of Obesity in Antipsychotic, Antidepressant and Antiepileptic Medication App 20100311719 - Nagy; Peter Literati ; et al.	2010-12-09
Pharmaceutical composition having prokinetic effect Grant 7,767,694 - Szilvassy , et al. August 3, 2	2010-08-03
Prevention and treatment of obesity Grant 7,763,601 - Nagy , et al. July 27, 2	2010-07-27
Synergistic pharmaceutical combination for the prevention or treatment of diabetes Grant 7,635,674 - Szilvassy , et al. December 22, 2	2009-12-22
Dose Reduction of a Cannabinoid CB1 Receptor Antagonist in the Treatment of Overweight or Obesity App 20090281143 - Nagy; Peter Literati ; et al.	2009-11-12
Prevention of obesity in antipsychotic, antidepressant and antiepileptic medication App 20080108602 - Nagy; Peter Literati ; et al.	2008-05-08
Prevention and Treatment of Obesity App 20080108673 - Nagy; Peter Literati ; et al.	2008-05-08
Pharmaceutical Composition Having Prokinetic Effect App 20070281972 - Szilvassy; Zoltan ; et al.	2007-12-06
Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same Grant 7,151,175 - Literati Nagy , et al. December 19, 2	2006-12-19
Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same App 20050165019 - Literati Nagy, Peter ; et al.	2005-07-28
Method for treating the pathological lesions of the skin that develop by ultraviolet radiation of the sunlight Grant 6,884,424 - Farkas , et al. April 26, 2	2005-04-26
Pharmaceutical composition that exhibits reduced side-effects comprising O-(3-piperidino-2-hydroxy-1-propyl)nicotinic acid amidoxime and a pyrimidine derivative with known antitumor activity Grant 6,838,469 - Sumegi January 4, 2	2005-01-04
Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxlmic acid derivative Grant 6,720,337 - Sumegi April 13, 2	2004-04-13
Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroximic acid derivative Grant 6,656,955 - Sumegi December 2, 2	2003-12-02
Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxImic acid derivative App 20030069270 - Sumegi, Balazs	2003-04-10
Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroximic acid derivative App 20030050345 - Sumegi, Balazs	2003-03-13
Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroximic acid derivative App 20020147213 - Sumegi, Balazs	2002-10-10
Pharmaceutical composition with antiviral activity containing an hydroxymic acid derivative and an antiviral agent Grant 6,451,851 - Sumegi September 17, 2	2002-09-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.